Why IMU is a multi multi bagger, page-31171

Hi Tenacity and Patience
As you clearly a good handle on the science that IMU are progressing ....I thought I would ask this question here , altho I am somewhat reluctant to do it .
Regarding ATX ..and their Announcement today , regarding progress with Pancreatic Cancer treatment ( their drug used in conjunction with Chemo ) and a difficu;t cancer to treat like IMU with Bile Duct Cancer treatment .
In part , shows my own ignorance ...and largely , I am not trying to really "compare "the two companies , as success will mean a lot to those patients being treated for either.
The part of the Announcement that struck a note here ..was this :
Edit :
At the outset of the study a statistical analysis was performed which identified that a patient cohort of
50 patients would be sufficient to allow the efficacy of our combination to be ascertained with
reasonable confidence if 15 or more responders (confirmed PR or CR) were recorded. A total of 55
advanced pancreatic patients have enrolled in the study since January 2024, with 21 patients still on
study at this time.
It hit home again , as regards IMU ...that these patient trials are a long , slow , process ..with little steps in increasing dosages , patients with different underlying medical conditions , ...advanced stage cancers or early detection ranging from the elderly to the very young .
Just perhaps a reminder ..to me at least , and in line with the Patience in your name ...that if you are still invested in IMU , its the belief /hope/ optimism ...that IMU will continue to produce highly positive results .
And at some point ..the market will be convinced these results will offer a sustainable breakthru .